274 related articles for article (PubMed ID: 27098250)
1. Enhanced Megakaryopoiesis and Platelet Activity in Hypercholesterolemic, B6-Ldlr-/-, Cdkn2a-Deficient Mice.
Wang W; Oh S; Koester M; Abramowicz S; Wang N; Tall AR; Welch CL
Circ Cardiovasc Genet; 2016 Jun; 9(3):213-22. PubMed ID: 27098250
[TBL] [Abstract][Full Text] [Related]
2. Cdkn2a is an atherosclerosis modifier locus that regulates monocyte/macrophage proliferation.
Kuo CL; Murphy AJ; Sayers S; Li R; Yvan-Charvet L; Davis JZ; Krishnamurthy J; Liu Y; Puig O; Sharpless NE; Tall AR; Welch CL
Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2483-92. PubMed ID: 21868699
[TBL] [Abstract][Full Text] [Related]
3. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D
Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B.
Congrains A; Kamide K; Oguro R; Yasuda O; Miyata K; Yamamoto E; Kawai T; Kusunoki H; Yamamoto H; Takeya Y; Yamamoto K; Onishi M; Sugimoto K; Katsuya T; Awata N; Ikebe K; Gondo Y; Oike Y; Ohishi M; Rakugi H
Atherosclerosis; 2012 Feb; 220(2):449-55. PubMed ID: 22178423
[TBL] [Abstract][Full Text] [Related]
5. Increased gene dosage of the Ink4/Arf locus does not attenuate atherosclerosis development in hypercholesterolaemic mice.
Fuster JJ; Molina-Sánchez P; Jovaní D; Vinué Á; Serrano M; Andrés V
Atherosclerosis; 2012 Mar; 221(1):98-105. PubMed ID: 22226369
[TBL] [Abstract][Full Text] [Related]
6. The tumour suppressor CDKN2A/p16
Wouters K; Deleye Y; Hannou SA; Vanhoutte J; Maréchal X; Coisne A; Tagzirt M; Derudas B; Bouchaert E; Duhem C; Vallez E; Schalkwijk CG; Pattou F; Montaigne D; Staels B; Paumelle R
Diab Vasc Dis Res; 2017 Nov; 14(6):516-524. PubMed ID: 28868898
[TBL] [Abstract][Full Text] [Related]
7. Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells.
Motterle A; Pu X; Wood H; Xiao Q; Gor S; Ng FL; Chan K; Cross F; Shohreh B; Poston RN; Tucker AT; Caulfield MJ; Ye S
Hum Mol Genet; 2012 Sep; 21(18):4021-9. PubMed ID: 22706276
[TBL] [Abstract][Full Text] [Related]
8. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
[TBL] [Abstract][Full Text] [Related]
9. p19(ARF) deficiency reduces macrophage and vascular smooth muscle cell apoptosis and aggravates atherosclerosis.
González-Navarro H; Abu Nabah YN; Vinué A; Andrés-Manzano MJ; Collado M; Serrano M; Andrés V
J Am Coll Cardiol; 2010 May; 55(20):2258-68. PubMed ID: 20381282
[TBL] [Abstract][Full Text] [Related]
10. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
[TBL] [Abstract][Full Text] [Related]
11. ANRIL expression is associated with atherosclerosis risk at chromosome 9p21.
Holdt LM; Beutner F; Scholz M; Gielen S; Gäbel G; Bergert H; Schuler G; Thiery J; Teupser D
Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):620-7. PubMed ID: 20056914
[TBL] [Abstract][Full Text] [Related]
12. Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk.
Burd CE; Jeck WR; Liu Y; Sanoff HK; Wang Z; Sharpless NE
PLoS Genet; 2010 Dec; 6(12):e1001233. PubMed ID: 21151960
[TBL] [Abstract][Full Text] [Related]
13. Islet biology, the CDKN2A/B locus and type 2 diabetes risk.
Kong Y; Sharma RB; Nwosu BU; Alonso LC
Diabetologia; 2016 Aug; 59(8):1579-93. PubMed ID: 27155872
[TBL] [Abstract][Full Text] [Related]
14. [Methylation profile of INK4B-ARF-INK4A locus in atherosclerosis].
Nazarenko MS; Markov AV; Lebedev IN; Slepsov AA; Koroleva YA; Frolov AV; Barbarash OL; Barbarash LS; Puzirev VP
Genetika; 2013 Jun; 49(6):783-7. PubMed ID: 24450202
[TBL] [Abstract][Full Text] [Related]
15. Direct CDKN2 Modulation of CDK4 Alters Target Engagement of CDK4 Inhibitor Drugs.
Green JL; Okerberg ES; Sejd J; Palafox M; Monserrat L; Alemayehu S; Wu J; Sykes M; Aban A; Serra V; Nomanbhoy T
Mol Cancer Ther; 2019 Apr; 18(4):771-779. PubMed ID: 30837298
[TBL] [Abstract][Full Text] [Related]
16. Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues.
Ramsey MR; Krishnamurthy J; Pei XH; Torrice C; Lin W; Carrasco DR; Ligon KL; Xiong Y; Sharpless NE
Cancer Res; 2007 May; 67(10):4732-41. PubMed ID: 17510401
[TBL] [Abstract][Full Text] [Related]
17.
Kong Y; Sharma RB; Ly S; Stamateris RE; Jesdale WM; Alonso LC
Diabetes; 2018 May; 67(5):872-884. PubMed ID: 29432124
[TBL] [Abstract][Full Text] [Related]
18. Functional genomics of the CDKN2A/B locus in cardiovascular and metabolic disease: what have we learned from GWASs?
Hannou SA; Wouters K; Paumelle R; Staels B
Trends Endocrinol Metab; 2015 Apr; 26(4):176-84. PubMed ID: 25744911
[TBL] [Abstract][Full Text] [Related]
19. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
Haviernik P; Schmidt M; Hu X; Wolff L
Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
[TBL] [Abstract][Full Text] [Related]
20. Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice.
Babaev VR; Yeung M; Erbay E; Ding L; Zhang Y; May JM; Fazio S; Hotamisligil GS; Linton MF
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1122-31. PubMed ID: 27102962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]